Possible attenuation of the G2 DNA damage cell cycle checkpoint in HeLa cells by extremely low frequency (ELF) electromagnetic fields

Cancer Cell International

Volumn 2, Issue , 2002, Pages

  Harris, Paul A ^a   Lamb, Justin ^b   Heaton, Brian ^c   Wheatley, Denys N ^d  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c UNIVERSITY OF ABERDEEN   (United Kingdom)

^d UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ATTENUATION; CELL CYCLE G2 PHASE; CELL CYCLE S PHASE; CELL FUNCTION; CELL SYNCHRONIZATION; CONTROLLED STUDY; DNA DAMAGE; ELECTROMAGNETIC FIELD; GAMMA IRRADIATION; HELA CELL; HUMAN; LEUKEMOGENESIS; MITOSIS INHIBITION;

EID: 0037883001     PISSN: 14752867     EISSN: None     Source Type: Journal    
DOI: 10.1186/1475-2867-2-3     Document Type: Article

References (43)

1. Wertheimer N, Leeper E: Electrical wiring configurations and childhood cancer. Amer J Epidem 1979, 109:273-284
2. Feychting M, Ahlbom A: Magnetic fields and cancer in children residing near Swedish high-voltage power lines. Amer J Epidemiol 1993, 138:467-481
3. Verkasalo PK, Pukkula E, Hongisto MY, Valjas JE, Heikkila KV, Koskenvuo M: Risk of cancer in Finnish children living close to power lines. Brit Med J 1993, 307:895-899
4. Linet MS, Hatch EE, Kleinerman RA, Robison LL, Kaune WT, Friedman DR, Severson RK, Haines CM, Hartsock CT, Niwa S, Wacholder S, Tarone RE: Residential exposure to magnetic fields and acute lymphoblastic leukemia in children. New Eng J Med 1997, 337:1-7
5. Campion EW: Power lines, cancer, and fear. New Engl J Med 1997, 337:44-45
6. Park RL: Currents of Fear. In "Voodoo science; the road from foolishness to fraud". Oxford University Press, Oxford 2000, 140-161
7. Adair RK: Constraints on biological weak effects of weak ELF electromagnetic fields. Physical Rev 1991, 43:1039-1040
8. Murphy JC, Kaden DA, Warren J, Sivak A: Power frequency electric and magnetic fields: a review of genetic toxicology. Mutat Res 1993, 296:221-240
9. Lane DP: p53, guardian of the genome. Nature 1992, 358:15-16
10. Williams GT: Programmed cell death: Apoptosis and oncogenesis. Cell 1991, 65:1097-1098
11. Harrington EA, Fanidi A, Evan GI: Oncogenes and cell death. Curr Opin Genet Dev 1994, 4:129
12. Murray A: Cell cycle checkpoints. Curr Opin Cell Biol 1994, 6:872-876
13. Elledge SJ: Cell cycle checkpoints: preventing an identity crisis. Science 1996, 274:1664-1672
14. Hartwell LH: Defects in a cell cycle checkpoint may be responsible for the genomic instability of cancer cells. Cell 1992, 71:543-546
15. Weinert TA, Lydall D: Cell cycle checkpoints, genetic instability and cancer. Semin Cancer Biol 1993, 4:129-140
16. Hollstein M, Rice K, Greenblatt MS, Soussi T, Fuchs R, Sorlie T, Hovig E, Smith-Sørensen B, Montesano R, Harris CC: Database of p53 gene somatic mutations in human tumors and cell lines. Nucleic Acids Res 1994, 22:3551-3555
17. Donehower LA, Harvey M, Slagle BL, McArthur MJ, Montgomery CA, Butel JS, Bradley A: Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 1992, 356:215-221
18. Harvey M, McArthur MJ, Montgomery CA, Butel JS, Bradley A, Donehower LA: Spontaneous and carcinogen induced tumorigenesis in p53-deficient mice. Nature Genet 1993, 5:225-229
19. Kastan MB, Onyekwere O, Sidransky D, Vogelstein B, Craig RW: Participation of p53 protein in the cellular response to DNA damage. Cancer Res 1991, 51:6304-6311
20. Kuerbitz SJ, Plunkett BS, Walsh WV, Kastan MB: Wild-type p53 is a cell cycle checkpoint determinant following irradiation. Proc Natl Acad Sci USA 1992, 89:7491-7495
21. Livingstone LR, White A, Spouse J, Livanos E, Jacks T, Tlsty TD: Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53. Cell 1992, 70:923-935
22. Yin Y, Tainsky MA, Bischoff FZ, Strong LC, Wahl GM: Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles. Cell 1992, 70:937-948
23. Harris PA: Biological effects of extremely low frequency magnetic fields. PhD Thesis ; University of Aberdeen. 1999
24. Litovitz TA, Krause D, Mullins JM: Effect of coherence time of the the applied magnetic field on ornithine decarboxylase activity. Biochem Biophys Res Comm 1991, 178:862-865
25. Hintenlang DE: Synergistic effects of ionising radiation and 60 Hz magnetic fields. Bioelectromagnetics 1993, 14:545-551
26. Rosenthal M, Obe G: Effects of 50 Hz electromagnetic fields on proliferation and on chromosomal alterations in human peripheral lymphocytes untreated or pretreated with chemical mutagens. Mutat Res 1989, 210:329-335
27. Lamb J, Wheatley DN: Cell killing by the novel imidazoacridinone antineoplastic agent, C-is inhibited at high concentrations coincident with dose-differentiated cell cycle perturbation. Br J Cancer 1311, 74:1359-1368
28. Vindeløv LL, Christensen IJ, Nissen NI: A detergent-trypsin method for the preparation of nuclei for flow cytometric DNA analysis. Cytometry 1983, 3:323-327
29. Scheffner M, Werness BA, Huibregtse JM, Levine AJ, Howley PM: The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 1990, 63:1129-1136
30. Hwang E-S, Naeger LK, DiMaio D: Activation of the endogeneous p53 growth inhibitory pathway in HeLa cervical carcinoma cells by expression of the bovine papillomavirus E2 gene. Oncogene 1996, 12:795-803
31. Kimler BF, Schneiderman MH, Leeper DB: Induction of concentration-dependent blockade in the G2 phase of the cell cycle by cancer chemotherapeutic agents. Cancer Res 1978, 38:809-814
32. Konopa J: G2 block induced by DNA crosslinking agents and its possible consequences. Biochem Pharmacol 1988, 37:2303-2309
33. Lock RB, Ross WE: Inhibition of p34cdc2 kinase activity by etoposide or irradiation as a mechanism of G2 arrest in Chinese hamster ovary cells. Cancer Res 1990, 50:3761-3766
34. Sørenson CM, Eastman A: Mechanism of cis-diamminedichloroplatinum (II)-induced cytotoxicity: role of G2 arrest and DNA double-strand breaks. Cancer Res 1988, 48:4484-4488
35. Gonzales AJ, Goldsworthy TL, Fox TR: The non-genotoxic chemical carcinogen phenobarbital delays G1 checkpoint response in B6C3F1 mouse hepatocytes. In: Keystone Symposium on 'Growth Control', Keystone CO, USA. 1997
36. McCallum HM: Biological and health effects associated with some non-ionising radiations. PhD Thesis, University of Aberdeen.1994
37. Norbury C, Nurse P: Animal cell cycles and their control. Annu Rev Biochem 1992, 61:441-470
38. Pines J, Hunter T: Isolation of a human cyclin cDNA: evidence for cyclin mRNA and protein regulation in the cell cycle and for interaction with p34cdc2. Cell 1989, 58:833-846
39. Draetta G, Beach D: Activation of cdc2 protein kinase during mitosis in human cells: cell cycle-dependent phosphorylation and subunit rearrangement. Cell 1988, 54:17-26
40. Morgan DO: Principles of CDK regulation. Nature 1995, 374:131-134
41. Matsushime H, Quelle DE, Shurtleff SA, Shibuya M, Sherr CJ, Kato JY: D-type cyclin-dependent kinase activity in mammalian cells. Mol Cell Biol 1994, 14:2066-2076
42. 2+-dependent gene expression in Jurkat cells. Cell Biol Internat 2002, 26:203-2098(doi:10.1006/cbir. 2001.0837)
43. Linström E, Linström P, Berglund A, Mild KH, Lundgren E: Intracellular calcium oscillations induced in a T cell line by a weak 50 Hz magnetic field. J Cell Physiol 1993, 156:395-398